A. Alfred Taubman Research Institute, Rogel Cancer Center, Departments of Ophthalmology & Visual Sciences and Pathology, University of Michigan and Section of Surgery, VA Ann Arbor Healthsystem, Ann Arbor, MI, USA.
Iowa Neuroscience Institute, Pappajohn Biomedical Institute, Department of Neurosurgery, Carver College of Medicine, University of Iowa, Iowa City, IA, USA.
Cell Rep Med. 2021 Feb 16;2(2):100190. doi: 10.1016/j.xcrm.2021.100190. Epub 2021 Jan 14.
The COVID-19 pandemic has affected almost every stakeholder in healthcare, including the vulnerable population of clinician investigators known as physician-scientists. In this commentary, Rao et al. highlight the underappreciated challenges and opportunities, and present solutions, for physician-scientists vis-à-vis the uniquely disruptive event of the pandemic.
COVID-19 大流行几乎影响了医疗保健的每个利益相关者，包括临床研究人员这一弱势群体，也就是所谓的医师科学家。在这篇评论中，Rao 等人强调了医师科学家在这场大流行这一独特的破坏性事件面前，所面临的被低估的挑战和机遇，并提出了一些解决方案。
